Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Avita Medical Inc (RCEL)

Avita Medical Inc (RCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 158,809
  • Shares Outstanding, K 30,777
  • Annual Sales, $ 71,610 K
  • Annual Income, $ -48,590 K
  • EBIT $ -45 M
  • EBITDA $ -42 M
  • 60-Month Beta 1.89
  • Price/Sales 2.41
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 128.76% (+6.54%)
  • Historical Volatility 79.17%
  • IV Percentile 38%
  • IV Rank 9.13%
  • IV High 807.43% on 02/18/26
  • IV Low 60.57% on 05/07/25
  • Expected Move (DTE 1) 0.52 (10.05%)
  • Put/Call Vol Ratio 14.29
  • Today's Volume 107
  • Volume Avg (30-Day) 49
  • Put/Call OI Ratio 0.33
  • Today's Open Interest 1,092
  • Open Int (30-Day) 1,043
  • Expected Range 4.64 to 5.68

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.35
  • Number of Estimates 1
  • High Estimate $-0.35
  • Low Estimate $-0.35
  • Prior Year $-0.53
  • Growth Rate Est. (year over year) +33.96%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.53 +45.61%
on 03/27/26
5.85 -12.14%
on 04/14/26
+0.52 (+11.26%)
since 03/16/26
3-Month
3.52 +46.02%
on 02/13/26
5.92 -13.18%
on 02/24/26
+1.24 (+31.79%)
since 01/16/26
52-Week
3.22 +59.63%
on 01/07/26
10.29 -50.05%
on 04/28/25
-3.88 (-43.02%)
since 04/16/25

Most Recent Stories

More News
AVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn Association

Recognition highlights pioneering contributions to modern burn care including development of RECELL ® Spray-On Skin™ VALENCIA, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- AVITA Medical ®...

AVH.AX : 1.450 (-4.92%)
RCEL : 5.14 (-0.39%)
AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting

Mean time to graft reduced to 13.6 days vs. 33.2 days real-world benchmark (~20 day reduction) Median time to graft of 11 days, with grafting as early as 5 days Study ongoing with full dataset...

AVH.AX : 1.450 (-4.92%)
RCEL : 5.14 (-0.39%)
AVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency Preparedness

Agreement ensures rapid nationwide access to RECELL® for burn mass casualty incidents, providing BARDA access to 3,000 units any time over the 10-year contract VALENCIA, Calif., April 08, 2026...

AVH.AX : 1.450 (-4.92%)
RCEL : 5.14 (-0.39%)
AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data

Cohealyx ® multi-center study interim analysis and new case data to be presented RECELL ® and PermeaDerm ® data reinforce a comprehensive approach to wound healing Evidence demonstrates potential...

AVH.AX : 1.450 (-4.92%)
RCEL : 5.14 (-0.39%)
AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference

VALENCIA, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- AVITA Medical ® , Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced...

AVH.AX : 1.450 (-4.92%)
RCEL : 5.14 (-0.39%)
AVITA Medical to Host Investor Webinar Briefing

VALENCIA, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders...

AVH.AX : 1.450 (-4.92%)
RCEL : 5.14 (-0.39%)
AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results

VALENCIA, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- AVITA Medical ® , Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions (“AVITA Medical,”...

AVH.AX : 1.450 (-4.92%)
RCEL : 5.14 (-0.39%)
Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies

First surgeon-reported case using RECELL ® , PermeaDerm ® , and Cohealyx ™ together in a single care pathway New clinical and tissue-level data on PermeaDerm and Cohealyx highlight...

AVH.AX : 1.450 (-4.92%)
RCEL : 5.14 (-0.39%)
AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook

VALENCIA, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- AVITA Medical ® , Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced...

AVH.AX : 1.450 (-4.92%)
RCEL : 5.14 (-0.39%)
AVITA Medical Announces Changes to its Board of Directors

Veteran healthcare executive Joe Woody joins the Board Lou Panaccio retires after over a decade of service VALENCIA, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- AVITA Medical ® , Inc. (ASX: AVH,...

AVH.AX : 1.450 (-4.92%)
RCEL : 5.14 (-0.39%)

Business Summary

AVITA Medical Inc. is a regenerative medicine company. It engages in developing and commercializing a technology platform which enables point-of-care autologous skin restoration for multiple unmet needs. AVITA Medical Inc., formerly known as AVITA Therapeutics Inc., is based in VALENCIA, Calif.

See More

Key Turning Points

3rd Resistance Point 6.06
2nd Resistance Point 5.85
1st Resistance Point 5.51
Last Price 5.14
1st Support Level 4.96
2nd Support Level 4.75
3rd Support Level 4.41

See More

52-Week High 10.29
Fibonacci 61.8% 7.59
Fibonacci 50% 6.76
Fibonacci 38.2% 5.92
Last Price 5.14
52-Week Low 3.22

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.